DENVER — As women are being diagnosed with cancer at younger ages, doctors are working to avoid that diagnosis altogether. Genetic testing can help spot an issue before it happens. In some places, ...
Despite major therapeutic advances, breast cancer remains prone to recurrence, particularly in patients with early-stage ...
Datopotamab deruxtecan received FDA approval for HR+/HER2– breast cancer, improving progression-free survival and overall ...
Radiation has been a staple of breast cancer treatment for decades, but a new study is casting doubt on whether it is ...
A research team at Oregon Health & Science University has discovered a promising new drug combination that may help people ...